Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson's disease model

Xin Qi, Brandon Davis, Yung Hsiao Chiang, Emily Filichia, Austin Barnett, Nigel H. Greig, Barry Hoffer, Yu Luo

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

p53, a stress response gene, is involved in diverse cell death pathways and its activation has been implicated in the pathogenesis of Parkinson's disease (PD). However, whether the neuronal p53 protein plays a direct role in regulating dopaminergic (DA) neuronal cell death is unknown. In this study, in contrast to the global inhibition of p53 function by pharmacological inhibitors and in traditional p53 knock-out (KO) mice, we examined the effect of DA specific p53 gene deletion in DAT-p53KO mice. These DAT-p53KO mice did not exhibit apparent changes in the general structure and neuronal density of DA neurons during late development and in aging. However, in DA-p53KO mice treated with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), we found that the induction of Bax and p53 up-regulated modulator of apoptosis (PUMA) mRNA and protein levels by MPTP were diminished in both striatum and substantia nigra of these mice. Notably, deletion of the p53 gene in DA neurons significantly reduced dopaminergic neuronal loss in substantia nigra, dopaminergic neuronal terminal loss at striatum and, additionally, decreased motor deficits in mice challenged with MPTP. In contrast, there was no difference in astrogliosis between WT and DAT-p53KO mice in response to MPTP treatment. These findings demonstrate a specific contribution of p53 activation in DA neuronal cell death by MPTP challenge. Our results further support the role of programmed cell death mediated by p53 in this animal model of PD and identify Bax, BAD and PUMA genes as downstream targets of p53 in modulating DA neuronal death in the in vivo MPTP-induced PD model. (Figure presented.) We deleted p53 gene in dopaminergic neurons in late developmental stages and found that DA specific p53 deletion is protective in acute MPTP animal model possibly through blocking MPTP-induced BAX and PUMA up-regulation. Astrocyte activation measured by GFAP positive cells and GFAP gene up-regulation in the striatum shows no difference between wt and DA-p53 ko mice.

Original languageEnglish
Pages (from-to)746-757
Number of pages12
JournalJournal of Neurochemistry
DOIs
Publication statusPublished - Sep 1 2016

Fingerprint

Dopaminergic Neurons
p53 Genes
Parkinsonian Disorders
Neurons
Genes
Cell death
Cell Death
Modulators
Parkinson Disease
Chemical activation
Substantia Nigra
Apoptosis
Animals
Up-Regulation
Animal Models
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Gene Deletion
Neurotoxins
4-phenyl-1,2,3,6-tetrahydropyridine
Knockout Mice

Keywords

  • apopotosis
  • cell specific knockout
  • MPTP
  • p53
  • parkinson's disease

ASJC Scopus subject areas

  • Biochemistry
  • Medicine(all)
  • Cellular and Molecular Neuroscience

Cite this

Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson's disease model. / Qi, Xin; Davis, Brandon; Chiang, Yung Hsiao; Filichia, Emily; Barnett, Austin; Greig, Nigel H.; Hoffer, Barry; Luo, Yu.

In: Journal of Neurochemistry, 01.09.2016, p. 746-757.

Research output: Contribution to journalArticle

Qi, Xin ; Davis, Brandon ; Chiang, Yung Hsiao ; Filichia, Emily ; Barnett, Austin ; Greig, Nigel H. ; Hoffer, Barry ; Luo, Yu. / Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson's disease model. In: Journal of Neurochemistry. 2016 ; pp. 746-757.
@article{82134ccfce8c4e6c8fe40e7de57d6a8d,
title = "Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson's disease model",
abstract = "p53, a stress response gene, is involved in diverse cell death pathways and its activation has been implicated in the pathogenesis of Parkinson's disease (PD). However, whether the neuronal p53 protein plays a direct role in regulating dopaminergic (DA) neuronal cell death is unknown. In this study, in contrast to the global inhibition of p53 function by pharmacological inhibitors and in traditional p53 knock-out (KO) mice, we examined the effect of DA specific p53 gene deletion in DAT-p53KO mice. These DAT-p53KO mice did not exhibit apparent changes in the general structure and neuronal density of DA neurons during late development and in aging. However, in DA-p53KO mice treated with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), we found that the induction of Bax and p53 up-regulated modulator of apoptosis (PUMA) mRNA and protein levels by MPTP were diminished in both striatum and substantia nigra of these mice. Notably, deletion of the p53 gene in DA neurons significantly reduced dopaminergic neuronal loss in substantia nigra, dopaminergic neuronal terminal loss at striatum and, additionally, decreased motor deficits in mice challenged with MPTP. In contrast, there was no difference in astrogliosis between WT and DAT-p53KO mice in response to MPTP treatment. These findings demonstrate a specific contribution of p53 activation in DA neuronal cell death by MPTP challenge. Our results further support the role of programmed cell death mediated by p53 in this animal model of PD and identify Bax, BAD and PUMA genes as downstream targets of p53 in modulating DA neuronal death in the in vivo MPTP-induced PD model. (Figure presented.) We deleted p53 gene in dopaminergic neurons in late developmental stages and found that DA specific p53 deletion is protective in acute MPTP animal model possibly through blocking MPTP-induced BAX and PUMA up-regulation. Astrocyte activation measured by GFAP positive cells and GFAP gene up-regulation in the striatum shows no difference between wt and DA-p53 ko mice.",
keywords = "apopotosis, cell specific knockout, MPTP, p53, parkinson's disease",
author = "Xin Qi and Brandon Davis and Chiang, {Yung Hsiao} and Emily Filichia and Austin Barnett and Greig, {Nigel H.} and Barry Hoffer and Yu Luo",
year = "2016",
month = "9",
day = "1",
doi = "10.1111/jnc.13706",
language = "English",
pages = "746--757",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson's disease model

AU - Qi, Xin

AU - Davis, Brandon

AU - Chiang, Yung Hsiao

AU - Filichia, Emily

AU - Barnett, Austin

AU - Greig, Nigel H.

AU - Hoffer, Barry

AU - Luo, Yu

PY - 2016/9/1

Y1 - 2016/9/1

N2 - p53, a stress response gene, is involved in diverse cell death pathways and its activation has been implicated in the pathogenesis of Parkinson's disease (PD). However, whether the neuronal p53 protein plays a direct role in regulating dopaminergic (DA) neuronal cell death is unknown. In this study, in contrast to the global inhibition of p53 function by pharmacological inhibitors and in traditional p53 knock-out (KO) mice, we examined the effect of DA specific p53 gene deletion in DAT-p53KO mice. These DAT-p53KO mice did not exhibit apparent changes in the general structure and neuronal density of DA neurons during late development and in aging. However, in DA-p53KO mice treated with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), we found that the induction of Bax and p53 up-regulated modulator of apoptosis (PUMA) mRNA and protein levels by MPTP were diminished in both striatum and substantia nigra of these mice. Notably, deletion of the p53 gene in DA neurons significantly reduced dopaminergic neuronal loss in substantia nigra, dopaminergic neuronal terminal loss at striatum and, additionally, decreased motor deficits in mice challenged with MPTP. In contrast, there was no difference in astrogliosis between WT and DAT-p53KO mice in response to MPTP treatment. These findings demonstrate a specific contribution of p53 activation in DA neuronal cell death by MPTP challenge. Our results further support the role of programmed cell death mediated by p53 in this animal model of PD and identify Bax, BAD and PUMA genes as downstream targets of p53 in modulating DA neuronal death in the in vivo MPTP-induced PD model. (Figure presented.) We deleted p53 gene in dopaminergic neurons in late developmental stages and found that DA specific p53 deletion is protective in acute MPTP animal model possibly through blocking MPTP-induced BAX and PUMA up-regulation. Astrocyte activation measured by GFAP positive cells and GFAP gene up-regulation in the striatum shows no difference between wt and DA-p53 ko mice.

AB - p53, a stress response gene, is involved in diverse cell death pathways and its activation has been implicated in the pathogenesis of Parkinson's disease (PD). However, whether the neuronal p53 protein plays a direct role in regulating dopaminergic (DA) neuronal cell death is unknown. In this study, in contrast to the global inhibition of p53 function by pharmacological inhibitors and in traditional p53 knock-out (KO) mice, we examined the effect of DA specific p53 gene deletion in DAT-p53KO mice. These DAT-p53KO mice did not exhibit apparent changes in the general structure and neuronal density of DA neurons during late development and in aging. However, in DA-p53KO mice treated with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), we found that the induction of Bax and p53 up-regulated modulator of apoptosis (PUMA) mRNA and protein levels by MPTP were diminished in both striatum and substantia nigra of these mice. Notably, deletion of the p53 gene in DA neurons significantly reduced dopaminergic neuronal loss in substantia nigra, dopaminergic neuronal terminal loss at striatum and, additionally, decreased motor deficits in mice challenged with MPTP. In contrast, there was no difference in astrogliosis between WT and DAT-p53KO mice in response to MPTP treatment. These findings demonstrate a specific contribution of p53 activation in DA neuronal cell death by MPTP challenge. Our results further support the role of programmed cell death mediated by p53 in this animal model of PD and identify Bax, BAD and PUMA genes as downstream targets of p53 in modulating DA neuronal death in the in vivo MPTP-induced PD model. (Figure presented.) We deleted p53 gene in dopaminergic neurons in late developmental stages and found that DA specific p53 deletion is protective in acute MPTP animal model possibly through blocking MPTP-induced BAX and PUMA up-regulation. Astrocyte activation measured by GFAP positive cells and GFAP gene up-regulation in the striatum shows no difference between wt and DA-p53 ko mice.

KW - apopotosis

KW - cell specific knockout

KW - MPTP

KW - p53

KW - parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=84983670770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983670770&partnerID=8YFLogxK

U2 - 10.1111/jnc.13706

DO - 10.1111/jnc.13706

M3 - Article

C2 - 27317935

AN - SCOPUS:84983670770

SP - 746

EP - 757

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

ER -